Funding is available for applied genomics research that drives the development, de-risking, and commercialization of biotech innovations across Alberta’s strategic sectors, including health, agriculture and agri-food, environment and energy, forestry, and technology platforms. To support the commercialization objectives and enhance development of IP, projects will be co-led by a Canadian for-profit enterprise and an Alberta-based academic researcher with the intention of generating commercial outcomes, intellectual property, and tangible socioeconomic benefits for Alberta.

Both the Regional (led by Genome Alberta) and the National (led by Genome Canada) Genomic Applications Partnership Programs support the Canadian Genomics Strategy. With a greater focus on commercialization, adoption, and scale up the GAPP programs will promote development and adoption of promising technologies. Genome Canada has provided $4 million over 4 years to Genome Alberta’s Regional GAPP.